Clinical Trial Update: A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) [Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 3 study (EPPIC-2) evaluating whether AST-120 can prevent progression of chronic kidney disease and asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-03-02